Search
Can Fite Biopharma Ltd
CANFAdd to Watchlist
4.700USD
+1.730+58.25%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
41.02KMarket Cap
LossP/E TTM
More Details of Can Fite Biopharma Ltd Company
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Can Fite Biopharma Ltd Info
Ticker SymbolCANF
Company nameCan Fite Biopharma Ltd
IPO dateSep 22, 2005
CEOFishman (Pnina)
Number of employees5
Security typeDepository Receipt
Fiscal year-endSep 22
Address10 Bareket Street, Kiryat Matalon
CityPETAH TIKVA
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryIsrael
Postal code49170
Phone97239241114
Websitehttps://www.canfite.com/
Ticker SymbolCANF
IPO dateSep 22, 2005
CEOFishman (Pnina)
Company Executives of Can Fite Biopharma Ltd
Name
Name/Position
Position
Shareholding
Change
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
FAQs
Who are the top five shareholders of Can Fite Biopharma Ltd?
The top five shareholders of Can Fite Biopharma Ltd are: Dr. Sari Fishman, Ph.D.
How many institutions hold shares of Can Fite Biopharma Ltd (CANF)?
As of 2026Q1, 28 institutions hold shares of Can Fite Biopharma Ltd, with a combined market value of approximately 32.13K, accounting for 1.50% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -81636.00.